Walter Modell

2.9k total citations
80 papers, 1.7k citations indexed

About

Walter Modell is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Physiology. According to data from OpenAlex, Walter Modell has authored 80 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pediatrics, Perinatology and Child Health, 14 papers in Pharmacology and 7 papers in Physiology. Recurrent topics in Walter Modell's work include Pharmaceutical studies and practices (14 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Pharmaceutical industry and healthcare (5 papers). Walter Modell is often cited by papers focused on Pharmaceutical studies and practices (14 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Pharmaceutical industry and healthcare (5 papers). Walter Modell collaborates with scholars based in United States and Guatemala. Walter Modell's co-authors include Arthur H. Hayes, Albert S. Kuperman, Jay Roberts, Theodore Greiner, Mckeen Cattell, Harry Gold, H Otto, NATHANIEL T. KWIT, J. Stanton King and Joseph Reilly and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Walter Modell

69 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Walter Modell United States 20 352 174 172 144 120 80 1.7k
Lloyd J. Roth United States 23 551 1.6× 186 1.1× 460 2.7× 123 0.9× 75 0.6× 63 1.7k
F.G. Sulman Israel 24 301 0.9× 292 1.7× 234 1.4× 277 1.9× 87 0.7× 175 2.0k
William Culp United States 13 726 2.1× 275 1.6× 168 1.0× 92 0.6× 53 0.4× 20 1.7k
G. E. W. Wolstenholme United Kingdom 23 425 1.2× 125 0.7× 136 0.8× 51 0.4× 216 1.8× 106 1.7k
A. James Giannini United States 32 622 1.8× 155 0.9× 452 2.6× 268 1.9× 107 0.9× 133 2.8k
M. Ginsburg United States 27 415 1.2× 255 1.5× 383 2.2× 59 0.4× 85 0.7× 91 2.3k
David Parkinson United States 28 611 1.7× 129 0.7× 344 2.0× 61 0.4× 113 0.9× 72 2.4k
Frederick A. Fuhrman United States 23 661 1.9× 262 1.5× 196 1.1× 56 0.4× 22 0.2× 57 1.9k
Kristen B. Eik‐Nes United States 35 915 2.6× 256 1.5× 107 0.6× 89 0.6× 39 0.3× 188 4.0k
Göran O. Steen Sweden 30 1.3k 3.6× 375 2.2× 106 0.6× 100 0.7× 29 0.2× 93 2.5k

Countries citing papers authored by Walter Modell

Since Specialization
Citations

This map shows the geographic impact of Walter Modell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walter Modell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walter Modell more than expected).

Fields of papers citing papers by Walter Modell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walter Modell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walter Modell. The network helps show where Walter Modell may publish in the future.

Co-authorship network of co-authors of Walter Modell

This figure shows the co-authorship network connecting the top 25 collaborators of Walter Modell. A scholar is included among the top collaborators of Walter Modell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walter Modell. Walter Modell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Modell, Walter. (1981). On the significance of significant. Clinical Pharmacology & Therapeutics. 30(1). 1–2. 47 indexed citations
2.
Modell, Walter. (1978). Clinical pharmacology: Reflections in my rear‐view mirror. Clinical Pharmacology & Therapeutics. 23(5). 497–504. 1 indexed citations
3.
Modell, Walter. (1971). Population, Species and Evolution. Clinical Pharmacology & Therapeutics. 12(2part1). 306–307. 192 indexed citations
4.
Modell, Walter. (1968). Malaria and Victory in Vietnam. Science. 162(3860). 1346–1352. 14 indexed citations
5.
Modell, Walter. (1968). On speech and silence and the FDA. Clinical Pharmacology & Therapeutics. 9(2). 139–141. 1 indexed citations
6.
Modell, Walter. (1968). How to HEW the FDA into shape. Clinical Pharmacology & Therapeutics. 9(3). 285–289. 1 indexed citations
7.
Modell, Walter. (1968). Advances in Pharmacology, Volume 5. Clinical Pharmacology & Therapeutics. 9(3). 405–406. 1 indexed citations
8.
Modell, Walter. (1967). FDA censorship. Clinical Pharmacology & Therapeutics. 8(3). 359–361. 3 indexed citations
9.
Modell, Walter, et al.. (1966). Pesticides in Clinical Practice: Identifition, Pharmacology, and Therapeutics. Clinical Pharmacology & Therapeutics. 7(5). 699–704. 2 indexed citations
10.
Modell, Walter. (1965). Advances in Drug Research. Clinical Pharmacology & Therapeutics. 6(1). 125–127. 154 indexed citations
11.
Kuperman, Albert S. & Walter Modell. (1964). Experimental Pharmacogenetics. Clinical Pharmacology & Therapeutics. 5(4). 529–530. 3 indexed citations
12.
Modell, Walter. (1963). Textbook of Endocrinology. Clinical Pharmacology & Therapeutics. 4(1). 138–139. 56 indexed citations
13.
Modell, Walter. (1963). Hazards of New Drugs. Science. 139(3560). 1180–1185. 12 indexed citations
14.
Modell, Walter. (1962). Clinical pharmacology of antianginal drugs. Clinical Pharmacology & Therapeutics. 3(1). 97–108. 18 indexed citations
15.
Modell, Walter. (1962). Clinical pharmacology: A definition. Clinical Pharmacology & Therapeutics. 3(2). 235–238. 8 indexed citations
16.
Roberts, Jay & Walter Modell. (1961). Pharmacological Evidence for the Importance of Catecholamines in Cardiac Rhythmicity. Circulation Research. 9(1). 171–176. 19 indexed citations
17.
Modell, Walter. (1960). Clinical Evaluation of New Drugs. Clinical Pharmacology & Therapeutics. 1(2). 268–270. 9 indexed citations
18.
Modell, Walter, et al.. (1960). Interactions between Pharmacodynamic and Placebo Effects in Drug Evaluations in Man. Nature. 185(4712). 538–539. 9 indexed citations
19.
Modell, Walter. (1958). Drugs of choice. 36 indexed citations
20.
Gold, Harry, Mckeen Cattell, Theodore Greiner, et al.. (1953). CLINICAL PHARMACOLOGY OF DIGOXIN. Journal of Pharmacology and Experimental Therapeutics. 109(1). 45–57. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lloyd J. Roth Breakdown of academic impact, for papers by F.G. Sulman Breakdown of academic impact, for papers by William Culp Breakdown of academic impact, for papers by G. E. W. Wolstenholme Breakdown of academic impact, for papers by A. James Giannini Breakdown of academic impact, for papers by M. Ginsburg Breakdown of academic impact, for papers by David Parkinson Breakdown of academic impact, for papers by Frederick A. Fuhrman Breakdown of academic impact, for papers by Kristen B. Eik‐Nes Breakdown of academic impact, for papers by Göran O. Steen
Rankless by CCL
2026